Similar articles

• Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance.

  Haustermans K, van der Kogel AJ, Vanacker B, van der Schueren E. Haustermans K, et al. Radiother Oncol. 1994 May;31(2):123-8. doi: 10.1016/0167-8140(94)90392-1. Radiother Oncol. 1994. PMID: 8066191
• Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.

  Simon JM, Lartigau E, Guichard M. Simon JM, et al. Radiother Oncol. 1993 Sep;28(3):203-7. doi: 10.1016/0167-8140(93)90059-h. Radiother Oncol. 1993. PMID: 8255997
• Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.

  Rojas A, Hirst VK, Calvert AS, Johns H. Rojas A, et al. Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):357-65. doi: 10.1016/0360-3016(95)02087-x. Int J Radiat Oncol Biol Phys. 1996. PMID: 8567336
• ARCON: a novel biology-based approach in radiotherapy.

  Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4. Lancet Oncol. 2002. PMID: 12473514 Review.
• Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

  Saunders M, Dische S. Saunders M, et al. Br J Cancer Suppl. 1996 Jul;27:S271-8. Br J Cancer Suppl. 1996. PMID: 8763896 Free PMC article. Review.